Hemoglobin is associated with serum high molecular weight adiponectin in japanese community-dwelling persons

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 3, 2011, Pages 182-189

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Kusunoki, Tomo ^a,b   Takayama, Shuzo ^a   Abe, Masanori ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

Confounding factor; Hemoglobin; HMW adiponectin

Indexed keywords

ADIPONECTIN; ANTILIPEMIC AGENT; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH MOLECULAR WEIGHT ADIPONECTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MOLECULAR WEIGHT; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79953317809     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.6379     Document Type: Article

References (34)

1. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 2003; 46: 459-469
2. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000; 20: 1595-1599
3. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T: Adiponectin as a biomarker of the metabolic syndrome. Circ J, 2004; 68: 975-981
4. Kato H, Kashiwagi H, Shiraga M, Tadokoro S, Kamae T, Ujiie H, Honda S, Miyata S, Ijiri Y, Yamamoto J, Maeda N, Funahashi T, Kurata Y, Shimomura I, Tomiyama Y, Kanakura Y: Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol, 2006; 26: 224-230
5. Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Wang Y: Adiponectin, an unlocking adipocytokine. Cardiovasc Ther, 2009; 27: 59-75
6. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem, 2003; 278: 40352-40363
7. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 2006; 29: 1357-1362
8. Seino Y, Hirose H, Saito I, Itoh H: High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism, 2007; 56: 1493-1499
9. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, Nakura J, Miki T, Makino H, Kohara K: Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab, 2008; 93: 715-722. 2007
10. Facchini FS, Carantoni M, Jeppesen J, Reaven GM: Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism, 1998; 47: 831-835
11. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corssi A, Ferrucci L, Paolisso G: New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia, 2001; 44: 1232-1237
12. Choi KM, Lee J, Kim YH, Kim KB, Kim DL, Kim SG, Shin DH, Kim NH, Park IB, Choi DS, Baik SH; Koreans-Southwest Seoul (SWS) Study: Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res Clin Pract, 2003; 60: 205-212
13. Ozdemir A, Sevinç C, Selamet U, Kamaci B, Atalay S: Ageand body mass index-dependent relationship between correction of iron deficiency anemia and insulin resistance in non-diabetic premenopausal women. Ann Saudi Med, 2007; 27: 356-361
14. Beige J, Heipmann K, Stumvoll M, Köner A, Kratzsch J: Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Expert Opin Ther Targets, 2009; 13: 163-173
15. Matsubara M, Namioka K, Katayose S: Relationships between plasma adiponectin and blood cells, hepatopancreatic enzymes in women. Thromb Page 19 Haemost, 2004; 91: 360-366
16. Aso Y, Suganuma R, Wakabayashi S, Hara K, Nakano T, Suetsugu M, Matsumoto S, Nakamachi T, Takebayashi K, Morita K, Inukai T: Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction. Transl Res, 2009; 154: 175-182
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419
18. The Japanese Society of Nephrology: Japanese version of GFR estimation. http://www.jsn.or.jp, 2007; Updated Oct 29
19. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001; 86: 1930-1935
20. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab, 2002; 87: 2764-2769
21. Takefuji S, Yatsuya H, Tamakoshi K, Otsuka R, Wada K, Matsushita K, Sugiura K, Hotta Y, Mitsuhashi H, Oiso Y, Toyoshima H: Smoking status and adiponectin in healthy Japanese men and women. Prev Med, 2007; 45: 471-475
22. Lin J, Hu FB, Curhan G: Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care, 2007; 30: 239-244
23. Fujimatsu D, Kotooka N, Inoue T, Nishiyama M, Node K: Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb, 2009; 16: 553-559
24. Kawamoto R, Tabara Y, Kohara K, Miki T, Ohtsuka N, Kusunoki T, Abe M: Smoking status is associated with serum high molecular adiponectin levels in communitydwelling Japanese men. J Atheroscler Thromb, 2010; 17: 423-430
25. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension, 2004; 43: 1318-1323
26. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes, 2002; 51: 2968-2974
27. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K: Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension, 2003; 42: 76-81
28. Yilmaz MI, Sonmez A, Saglam M, Gulec M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C: Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease. Kidney Int, 2009; 75: 1316-1321
29. Grinshtein N, Bamm VV, Tsemakhovich VA, Shaklai N: Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. Biochemistry, 2003; 42: 6977-6985
30. Kutlu M, Sonmez A, Genc H, Erdem G, Tapan S, Celebi G, Haymana C, Taslipinar A, Uckaya G, Erbil MK: Relationship between hemoglobin and CD40 ligand in prediabetes. Clin Invest Med, 2009; 32: E244
31. Schöbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P: Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation, 2002; 106: 2888-2893
32. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001; 50: 2094-2099
33. Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T, Abe M: Alcohol consumption is associated with decreased insulin resistance independent of body mass index in Japanese community-dwelling men. Tohoku J Exp Med, 2009; 218: 331-337
34. Kearney MT, Duncan ER, Kahn M, Wheatcroft SB: Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol, 2008; 93: 158-163